
High-profile figures often share misleading health information, highlighting the need for trusted and evidence-based content in social media discussions.

High-profile figures often share misleading health information, highlighting the need for trusted and evidence-based content in social media discussions.

Experts at the Milken Institute address better ways of adopting pharmacy services within the greater health care ecosystem.

Conflicting health guidance from authorities creates confusion and erodes public trust, impacting access to medical care and long-term health outcomes.

After nearly 20 years of pneumococcal conjugate vaccine use in the Portuguese vaccine schedule, researchers explore serotype distribution in bacteria causing adult invasive pneumococcal disease (IPD).

The CDC argues the statement “vaccines do not cause autism” is not evidence based because studies have not ruled out the possibility that vaccines do not contribute to the development of autism.

In a conversation with NCPDP’s Rick Sage, he explored the lasting effects on pharmacy stemming from the record-breaking government shutdown.

Regeneron Pharmaceuticals’ newest drug will be the first and only approved flexible treatment option for retinal vein occlusion.

The FDA approves denosumab biosimilars Osvyrti and Jubereq, expanding treatment options for osteoporosis and bone-related conditions.

A study reveals declining support for COVID-19 measures over time, highlighting the critical role of pharmacists in providing essential health education.

Patients tend to trust their physician to deprescribe more than their community pharmacist.

In this episode, Natalie DiPietro Mager, PharmD, PhD, MPH, meets with pharmacists from Ohio State University to discuss smoking trends among women.

Rick Sage, executive vice president of innovation and standards with the NCPDP, discusses the nuances of billing under either Medicare Part B or D.

Pharmacists enhance diabetes care through text messaging interventions, improving medication adherence and glycemic control in patients with complex treatment plans.

Researchers explore the no-cost uptake of 2 separate emergency contraception methods.

Study authors explore online purchasing habits for prescription-only and OTC medications.

A study reveals first-trimester SARS-CoV-2 infection increases neonatal risks and highlights disparities in testing among pregnant women across demographics.

Researchers explore OTC medication misuse among adults over 65 in Saudi Arabia.

A recent review highlights cardiovascular risks linked to albuterol use in asthma treatment, urging safer alternatives and enhanced patient monitoring strategies.

Researchers address the potential association of access to maternal care with the increased risk of infant mortality.

US adults show an increase in recreational activity post-COVID-19, but lingering cardiovascular risks from infection highlight the need for ongoing health vigilance.

The study highlights disparities in COVID-19 vaccine access, revealing urban pharmacies excel while rural areas face significant challenges, urging policy changes for equity.

With disease cases increasing substantially between 2012 and 2024, higher-valent vaccines are necessary to protect against nonvaccine serotypes and invasive pneumococcal disease.

Due to the lived realities and trajectory of risk throughout their lifetime, researchers believe women require novel approaches in their cardiovascular health care needs.

Researchers explore highly engaged social media posts related to glucagon-like peptide-1 receptor agonists, attention deficit/hyperactivity disorder stimulants, and autoimmune biologics.

This episode explores ongoing developments in pharmacy law, specifically for independent pharmacies and their representatives who attended the 2025 NCPA Convention & Expo.

This collaboration is designed to bring resources addressing pharmacy shortages to the fingertips of the general public.

A study shows dupilumab significantly improves symptoms of allergic fungal rhinosinusitis, offering hope for effective treatment options.

The event will explore the importance of advocacy, gathering experts all across community pharmacy to discuss improving patient access and education.

With a new year approaching, pharmacy law experts joined Over the Counter to recap some of the key events regarding state- and federal-level PBM reform throughout 2025.

With evidence of antiobesity properties in human trials, berberine could be an OTC phytotherapeutic option for weight loss.